Literature DB >> 9120307

Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide.

N Vita1, S Lefort, P Sozzani, R Reeb, S Richards, L K Borysiewicz, P Ferrara, M O Labéta.   

Abstract

Soluble CD14 (sCD14) has been found to bind LPS and mediate LPS activation of several cell types. It has been postulated that sCD14-LPS complexes induce cell responses by interacting with a cell surface structure, which, in turn, triggers cell activation. There has been no biochemical evidence, however, for a direct interaction of sCD14 with a cell surface structure, and the putative receptor has not been identified. To rigorously test this hypothesis, we studied the interaction of human rsCD14 with cells in the absence of serum and in the presence and the absence of LPS. We found 1) there was specific and saturable binding of 125I-sCD14, indicative of a typical receptor-ligand interaction, to several cell types, including endothelial cells, epithelial cells, astrocytes, and human monocytes; 2) specific binding to all the cell types and IL-6 induction in membrane-bound CD14 (mCD14)-negative cells occurred only when both sCD14 and LPS were present; 3) competitive displacement experiments of 125I-sCD14 binding to astrocytes and Scatchard plots revealed a binding of high affinity (Kd = 3.3 +/- 0.4 nM) and approximately 25,000 single class binding sites/cell; 4) the steady state for the association of 125I-sCD14 was obtained after 180-200 min; 5) chemical cross-linking experiments revealed the association of sCD14 with a binding structure of approximately 216 kDa; 6) binding of 125I-sCD14 to CD14-expressing cell transfectants was about 50% lower than that to nontransfected cells. Maximal binding, however, was recovered after removing mCD14, suggesting that the sCD14-LPS receptor may also interact with mCD14. These results provide direct biochemical evidence for the existence of a cell surface signal-mediating binding structure for LPS-bearing sCD14 and suggest that this structure may represent the signaling unit of the postulated multimeric LPS receptor in mCD14-bearing cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9120307

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Lipopolysaccharide and its analog antagonists display differential serum factor dependencies for induction of cytokine genes in murine macrophages.

Authors:  P Y Perera; N Qureshi; W J Christ; P Stütz; S N Vogel
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Elevated serum concentrations of soluble CD14 in HIV- and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment.

Authors:  S D Lawn; M O Labeta; M Arias; J W Acheampong; G E Griffin
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

3.  Overexpression of a novel lymphocyte population, positive for an intracellular CD14-like antigen, in patients positive for human immunodeficiency virus type 1.

Authors:  Dan Turner; Michael Hoffman; Israel Yust; Mordechai Fried; Margalit Bleiberg; Boris Tartakovsky
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

4.  Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway.

Authors:  T van der Bruggen; S Nijenhuis; E van Raaij; J Verhoef; B S van Asbeck
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

5.  CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited.

Authors:  D P Funda; L Tucková; M A Farré; T Iwase; I Moro; H Tlaskalová-Hogenová
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

6.  Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro.

Authors:  Harald Langeggen; Knut Erik Berge; Egil Johnson; Geir Hetland
Journal:  Inflammation       Date:  2002-06       Impact factor: 4.092

Review 7.  Cytokines and Soluble Receptors in Breast Milk as Enhancers of Oral Tolerance Development.

Authors:  Bassel Dawod; Jean S Marshall
Journal:  Front Immunol       Date:  2019-01-22       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.